JP2005518187A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518187A5
JP2005518187A5 JP2003526954A JP2003526954A JP2005518187A5 JP 2005518187 A5 JP2005518187 A5 JP 2005518187A5 JP 2003526954 A JP2003526954 A JP 2003526954A JP 2003526954 A JP2003526954 A JP 2003526954A JP 2005518187 A5 JP2005518187 A5 JP 2005518187A5
Authority
JP
Japan
Prior art keywords
gβγ
phosducin
contractility
compound
test compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003526954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518187A (ja
Filing date
Publication date
Priority claimed from US09/951,030 external-priority patent/US20030049258A1/en
Application filed filed Critical
Publication of JP2005518187A publication Critical patent/JP2005518187A/ja
Publication of JP2005518187A5 publication Critical patent/JP2005518187A5/ja
Withdrawn legal-status Critical Current

Links

JP2003526954A 2001-09-11 2002-09-11 心臓、心筋または心筋細胞の収縮能を増大する方法 Withdrawn JP2005518187A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/951,030 US20030049258A1 (en) 2001-09-11 2001-09-11 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
PCT/EP2002/010205 WO2003022882A2 (en) 2001-09-11 2002-09-11 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle

Publications (2)

Publication Number Publication Date
JP2005518187A JP2005518187A (ja) 2005-06-23
JP2005518187A5 true JP2005518187A5 (https=) 2006-01-05

Family

ID=25491176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526954A Withdrawn JP2005518187A (ja) 2001-09-11 2002-09-11 心臓、心筋または心筋細胞の収縮能を増大する方法

Country Status (5)

Country Link
US (1) US20030049258A1 (https=)
EP (1) EP1497425A2 (https=)
JP (1) JP2005518187A (https=)
AU (1) AU2002338665A1 (https=)
WO (1) WO2003022882A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8183350B2 (en) 2002-05-04 2012-05-22 Acorda Therapeutics, Inc. Compositions and methods for promoting neuronal outgrowth
EP1477475A1 (en) * 2003-05-16 2004-11-17 Procorde GmbH Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
EP3211084B1 (en) * 2003-05-16 2019-03-27 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of cns
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
MXPA06013345A (es) 2004-05-18 2008-10-31 Acorda Therapeutics Inc Metodos para purificar condrointinasa y sus formulaciones estables.
JP5189985B2 (ja) 2005-09-26 2013-04-24 アコーダ セラピューティクス、インク． コンドロイチナーゼａｂｃｉ変異体を用いた組成物およびその使用方法
CA3009034C (en) 2006-10-10 2020-08-18 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
WO2019155041A1 (en) * 2018-02-12 2019-08-15 Vib Vzw Gβγ COMPLEX ANTIBODIES AND USES THEREOF
AU2024213547A1 (en) * 2023-01-31 2025-08-14 Fujifilm Corporation Drug evaluation method, reagent and kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7427098A (en) * 1997-03-10 1998-09-29 Boehringer Mannheim Gmbh Inhibitors of g-protein-beta/gamma subunit function
US6030943A (en) * 1997-05-07 2000-02-29 Crumb; William J. Dehydrodidemnin B as an L-type calcium channel enhancer
AUPQ480399A0 (en) * 1999-12-22 2000-02-03 Commonwealth Scientific And Industrial Research Organisation Unsaturated fatty acids and their uses in therapy

Similar Documents

Publication Publication Date Title
Yamashita et al. Characterization of multiple members of the HSP70 family in platyfish culture cells: molecular evolution of stress protein HSP70 in vertebrates
Chien et al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response
WO1999019471A1 (en) Models and treatments for cardiac hypertrophy in relation with nf-at3 function
WO2008063330A2 (en) Molecular control of brown fat differentiation and energy expenditure
JP2005518187A5 (https=)
JP2002508923A (ja) 心肥大において差示的に発現される遺伝子、ならびに処置および診断におけるそれらの使用
Hein et al. Receptor and binding studies
Huang et al. Transforming growth factor-β induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK
US7144706B2 (en) Methods of modulating localization and physiological function of IP3 receptors
WO2003073107A2 (en) Neuropeptide receptor and uses thereof
Dai et al. Characterization of a novel gene encoding zinc finger domains identified from expressed sequence tags (ESTs) of a human heart cDNA database
AU2004223739B2 (en) Cyclic AMP response element activator proteins and uses related thereto
EP1090989A1 (en) Human g-protein-coupled receptor
Papanastasiou et al. Cloning and phylogenetic analysis of the alpha subunit of the eighth complement component (C8) in rainbow trout
WO2002004491A2 (en) Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
US20050221359A1 (en) Cospeptin, cosmedin and their uses
JPH1118782A (ja) 新規なヒト・ニューロテンシン・レセプター２型およびそのスプライス変種
Iio et al. A novel membrane guanylyl cyclase expressed in medaka (Oryzias latipes) intestine
Mishra et al. Expression of cGMP-dependent protein kinase in human atrium
US20030078376A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
JP2001245674A (ja) 新規ポリペプチド
CA2432278A1 (en) Methods and compositions relating to cardiac-specific nuclear regulatory factors
JP2003522522A (ja) 新規ヒトカルシウム感受性カリウムチャンネルサブユニット
US20030119024A1 (en) Genes and proteins associated with T cell activation
WO2001012213A2 (en) Ttp-related zinc finger domains and methods of use